EMPLOYMENT AGREEMENTEmployment Agreement • November 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledNovember 5th, 2021 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is dated as of July 12, 2021, between Novavax, Inc., (“Novavax” or the “Company”) a Delaware corporation having its principal office at 21 Firstfield Road, Gaithersburg, MD 20878, and James P. Kelly, an individual having a current mailing address of [***] (“Executive”).
CONSULTING AGREEMENTConsulting Agreement • November 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledNovember 5th, 2021 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (“Agreement”) is made effective as of August 10, 2021 (the “Effective Date”) and entered into by and between NOVAVAX, INC. (“Novavax”), a Delaware corporation, having a place of business at 21 Firstfield Road, Gaithersburg, Maryland 20878 and GREGORY F. COVINO (“Consultant”), an individual, having an address at [***]. Novavax and Consultant may be referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
CERTAIN INFORMATION IDENTIFIED WITH [***] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED SUPPLY AND LICENSE AGREEMENT BETWEEN...Supply and License Agreement • November 5th, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 5th, 2021 Company IndustryThis Amended and Restated Supply and License Agreement (the “Restated Agreement”) is entered into and made effective as of the last date of signature by the Parties to this Agreement (the “Effective Date of Restatement”), by and between Serum Institute of India Private Limited., an Indian company having its principal place of business at 212/2, Off Soli Poonawalla Road, Hadapsar, Pune 411028 (“SIIPL”, which expression shall, unless repugnant to the context thereof, mean and include its Affiliates, successors and permitted assigns), and Novavax, Inc., a Delaware, USA corporation having its principal place of business at 21 Firstfield Road, Gaithersburg, MD 20878 USA (“Novavax”, which expression shall, unless repugnant to the context thereof, mean and include its Affiliates). Novavax and SIIPL may each be referred to herein individually as a “Party” and collectively as the “Parties.”